Alfasigma S.p.A — 10 Licensed Medicines in Ireland

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 10 products held by Alfasigma S.p.A

Medicine	Active substance	Licence holder	Status
Eurartesim 320 mg/40 mg film-coated tablets EU/1/11/716/001-004	Piperaquine phosphate, Dihydroartemisinin	Alfasigma S.p.A	—
Jyseleca 100 mg film-coated tablets EU/1/20/1480/001-002	Filgotinib maleate	Alfasigma S.p.A	—
Jyseleca 200 mg film-coated tablets EU/1/20/1480/003-004	Filgotinib maleate	Alfasigma S.p.A	—
Lumeblue 25 mg prolonged-release tablets EU/1/20/1470/001	Methylthioninium chloride	Alfasigma S.p.A	—
Rifaximin Alfasigma 550 mg film-coated tablets PA2206/001/001	Rifaximin	Alfasigma S.p.A	Not marketed
Synacthen 250 micrograms/ml solution for injection PA2206/002/001	Tetracosactide acetate	Alfasigma S.p.A	Not marketed
Syntocinon Ampoules 10 IU/ml solution for injection/infusion PA2206/003/002	Oxytocin	Alfasigma S.p.A	Not marketed
Syntocinon Ampoules 5 IU/ml solution for injection/infusion PA2206/003/001	Oxytocin	Alfasigma S.p.A	Marketed
Zaditen 1 mg Tablets PA2206/004/002	KETOTIFEN FUMARATE	Alfasigma S.p.A	Marketed
Zaditen 1mg/5ml oral solution PA2206/004/001	Ketotifen hydrogen fumarate	Alfasigma S.p.A	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.

Alfasigma S.p.A — Licensed Medicines